Course Content
Introduction
How to use this course
You don't currently have access to this content
Introduction to Seasonal Influenza 2024/25
You don't currently have access to this content
The Nature of Flu
Type – Flu 2024/25
You don't currently have access to this content
Symptoms – Flu 2024/25
You don't currently have access to this content
Transmission – Flu 2024/25
You don't currently have access to this content
Case Outcomes – Flu 2024/25
You don't currently have access to this content
The Annual Flu Programme 2024/25
This Year’s Programme – Flu 2024/25
You don't currently have access to this content
Live attenuated influenza vaccine – LAIV – 2024/25
You don't currently have access to this content
Quadrivalent influenza cell cultured vaccine – QIVc – 2024/25
You don't currently have access to this content
Adjuvanted quadrivalent influenza vaccine – aQIV – 2024/25
You don't currently have access to this content
High dose quadrivalent influenza vaccine – QIV-HD – 2024/25
You don't currently have access to this content
Quadrivalent inactivated influenza vaccine – QIVe – 2024/25
You don't currently have access to this content
Groups for the national flu immunisation programme 2024/25
You don't currently have access to this content
Vaccine Administration
Vaccine Administration (Flu)
You don't currently have access to this content
Simple Summaries
Age related guide to which vaccine to offer – 2024/25
You don't currently have access to this content
Vaccine summaries – Seasonal Influenza 2024/25
You don't currently have access to this content
Seasonal Influenza FAQs
You don't currently have access to this content
Summary Session and Further Reading
You don't currently have access to this content
Seasonal Influenza – 2024/25 – Final Assessment
You don't currently have access to this content